Measles Antibodies (IgG, IgM), Diagnostic

Measles Antibodies (IgG, IgM), Diagnostic

Test Code

34166
86765 (x2)
34166
86765 (x2)
In-home collection may be available in your area for purchase through Quest Mobile.

Clinical Significance

Measles Antibodies (IgG, IgM), Diagnostic - Measles, also known as Rubeola, causes fever, irritability, respiratory illness, and the characteristic skin rash. Immunization has greatly diminished the incidence of measles. The presence of IgG is consistent with immunity or prior exposure. IgM is consistent with current or recent infection. IgM tests can generate false positive results and low levels of IgM can persist for longer than 12 months.

Test Details

Methodology

Immunoassay (IA) • Immunofluorescence Assay (IFA)

Assay Category

Measles Antibodies (IgM): This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Reference Range(s)

Measles Antibody (IgG)

AU/mLInterpretation
<13.50Negative
13.50-16.49Equivocal
>16.49Positive
The presence of measles IgG suggests immunization or past or current infection with measles virus.

Measles Antibody (IgM)
TiterInterpretation
<1:20Antibody not detected
≥1:20Antibody detected
The traditional serologic diagnosis of measles requires a significant rise in antibody titer between acute and convalescent sera. However, detection of IgM antibody in a single specimen may indicate acute disease.
Correct interpretation of serologic data depends upon the proper timing of specimen collection in relation to rash onset. This timing is particularly important for interpreting negative IgM results, since IgM antibody peaks approximately 10 days after rash onset and is usually undetectable 30 days after rash onset.

Alternative Name(s)

Rubeola IgG and IgM Antibodies

LOINC® Codes, Performing Laboratory

Methodology

Immunoassay (IA) • Immunofluorescence Assay (IFA)
Measles Antibodies (IgM): This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Reference Range(s)

Measles Antibody (IgG)
AU/mLInterpretation
<13.50Negative
13.50-16.49Equivocal
>16.49Positive
The presence of measles IgG suggests immunization or past or current infection with measles virus.

Measles Antibody (IgM)
TiterInterpretation
<1:20Antibody not detected
≥1:20Antibody detected
The traditional serologic diagnosis of measles requires a significant rise in antibody titer between acute and convalescent sera. However, detection of IgM antibody in a single specimen may indicate acute disease.
Correct interpretation of serologic data depends upon the proper timing of specimen collection in relation to rash onset. This timing is particularly important for interpreting negative IgM results, since IgM antibody peaks approximately 10 days after rash onset and is usually undetectable 30 days after rash onset.

Alternative Name(s)

Rubeola IgG and IgM Antibodies

Preferred Specimen(s)

1 mL serum

Minimum Volume

0.5 mL

Transport Container

Transport tube

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 4 days
  • Refrigerated: 7 days
  • Frozen: 30 days

Setup Schedule

1 mL serum
0.5 mL
Transport tube

Room temperature

Room temperature: 4 days
Refrigerated: 7 days
Frozen: 30 days
In-home collection may be available in your area for purchase through Quest Mobile.
Test Details

Clinical Significance

Test Resources

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.

The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.